Abstract: A pharmaceutical formulation of a pharmaceutically active protein including an effective amount of a protein or a combination of proteins, a chitosan A and at least one statistic polysaccharide B. Also, a kit including the at least one first container containing the chitosan A and the statistic polysaccharide B and at least one second container containing the protein or combination of proteins. Further, the pharmaceutical formulation or the kit for use in the treatment of cancer, typically breast or gastric cancer.
Type:
Application
Filed:
February 3, 2023
Publication date:
May 1, 2025
Applicants:
GCS INSTITUT DE CANCEROLOGIE STRASBOURG EUROPE, MEXBRAIN, UNIVERSITE CLAUDE BERNARD LYON 1, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE JEAN MONNET SAINT ETIENNE, INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE LYON
Inventors:
Alexandre DETAPPE, Xavier PIVOT, Pierre COLIAT, Olivier TILLEMENT, Thomas GREA, François LUX, Laurent DAVID